Calcipotriol 50micrograms/ml scalp solution Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

calcipotriol 50micrograms/ml scalp solution

cst pharma ltd - calcipotriol monohydrate - cutaneous solution - 50microgram/1ml

Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

calcipotriol 0.005% / betamethasone dipropionate 0.05% ointment

medihealth (northern) ltd - calcipotriol monohydrate; betamethasone dipropionate - cutaneous ointment - 50microgram/1gram ; 500microgram/1gram

Calcipotriol 50micrograms/g ointment Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

calcipotriol 50micrograms/g ointment

medihealth (northern) ltd - calcipotriol - cutaneous ointment - 50microgram/1gram

Calcipotriol 50micrograms/ml scalp solution Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

calcipotriol 50micrograms/ml scalp solution

medihealth (northern) ltd - calcipotriol monohydrate - cutaneous solution - 50microgram/1ml

Calcipotriol/Betamethasone (Teva) Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

calcipotriol/betamethasone (teva)

teva pharma (new zealand) limited - betamethasone dipropionate 0.643 mg/g equivalent to betamethasone base 0.500 mg/g; calcipotriol 0.05 mg/g;   - topical ointment - active: betamethasone dipropionate 0.643 mg/g equivalent to betamethasone base 0.500 mg/g calcipotriol 0.05 mg/g   excipient: butylated hydroxytoluene liquid paraffin polyoxypropylene monostearyl ether white soft paraffin - calcipotriol /betamethasone (teva) is indicated for the once daily topical treatment of plaque-type psoriasis vulgaris amenable to topical therapy in adult patients 18 years and older.

Calcipotriol/Betamethasone Sandoz 50/500 Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

calcipotriol/betamethasone sandoz 50/500

sandoz new zealand limited - betamethasone dipropionate 0.643 mg/g equivalent to betamethasone 0.50mg; calcipotriol monohydrate 0.0522 mg/g equivalent to calcipotriol 0.050mg - topical ointment - active: betamethasone dipropionate 0.643 mg/g equivalent to betamethasone 0.50mg calcipotriol monohydrate 0.0522 mg/g equivalent to calcipotriol 0.050mg excipient: d-alpha tocoferol liquid paraffin oleyl alcohol white soft paraffin - calcipotriol and betamethasone ointment is indicated for the once daily topical treatment of plaque-type psoriasis vulgaris amenable to topical therapy in patients 18 years and older.

Daivonex Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

daivonex

leo pharma limited - calcipotriol 50 µg/g - topical ointment - 50 mcg/g - active: calcipotriol 50 µg/g excipient: dibasic sodium phosphate dihydrate disodium edetate dihydrate dl-alpha tocopherol liquid paraffin polyoxyethylene stearyl ether propylene glycol purified water white soft paraffin

CALCIL 50 MICROGRAM/G CREAM 0.05 mg/g Cream Irlanti - englanti - HPRA (Health Products Regulatory Authority)

calcil 50 microgram/g cream 0.05 mg/g cream

rowex ltd - calcipotriol anhydrous - cream - 0.05 mg/g

CALCIL 0.05 mg/g Ointment Irlanti - englanti - HPRA (Health Products Regulatory Authority)

calcil 0.05 mg/g ointment

rowex ltd - calcipotriol anhydrous - ointment - 0.05 mg/g

CALCIL 50 MICROGRAMS/ML CUTANEOUS SOLUTION 50 Microgram/ML Cutaneous Solution Irlanti - englanti - HPRA (Health Products Regulatory Authority)

calcil 50 micrograms/ml cutaneous solution 50 microgram/ml cutaneous solution

rowex ltd - calcipotriol anhydrous - cutaneous solution - 50 microgram/ml